Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Implication of TRPM4 channel in ischemia-reperfusion injury

19 views

Published on

Ischemic heart disease often causes heart failure. During ischemia-reperfusion (I/R), excessive reactive oxygen species (ROS), including hydrogen peroxide (H2O2), are produced in cardiac tissue, where they induce cell death. We previously reported that a TRPM4 channel inhibitor 9-Phenanthrol protects cardiac I/R injury in the excised rat heart. Based on this finding, we hypothesized that TRPM4 channels are involved in the pathophysiology of the cardiac I/R injury. We confirmed that intravenous application of 9-Phenanthrol mitigated the development of myocardial infarction caused by the occlusion of the left anterior descending artery in rats. Positive expression of TRPM4 channels in the ventricular cardiomyocytes was confirmed by immuno-histochemistry. To evaluate the toxic effect of ROS on cardiac cells, we measured cellular viability of H9c2 cardiomyocytes underwent H2O2 challenge. Pretreatment of 9-Phenanthrol preserved cellular viability. Furthermore, knockdown of TRPM4 channels preserved the viability of H9c2 cardiomyocytes exposed to H2O2. These results suggest that TRPM4 channels are involved in development of cardiac ischemia-reperfusion injury.

Published in: Science
  • Be the first to comment

  • Be the first to like this

Implication of TRPM4 channel in ischemia-reperfusion injury

  1. 1. Implication of TRPM4 channel in ischemia-reperfusion injury Ken Takahashi, Keiji Naruse Cardiovascular Physiology, Okayama Univ. Grad. Sch. Med. Dent. Pharmaceut. Sci., Okayama, Japan Abstract Ischemic heart disease often causes heart failure. During ischemia-reperfusion (I/R), excessive reactive oxygen species (ROS), including hydrogen peroxide (H2O2), are produced in cardiac tissue, where they induce cell death. We previously reported that a TRPM4 channel inhibitor 9-Phenanthrol protects cardiac I/R injury in the excised rat heart. Based on this finding, we hypothesized that TRPM4 channels are involved in the pathophysiology of the cardiac I/R injury. We confirmed that intravenous application of 9-Phenanthrol mitigated the development of myocardial infarction caused by the occlusion of the left anterior descending artery in rats. Positive expression of TRPM4 channels in the ventricular cardiomyocytes was confirmed by immuno- histochemistry. To evaluate the toxic effect of ROS on cardiac cells, we measured cellular viability of H9c2 cardiomyocytes underwent H2O2 challenge. Pretreatment of 9-Phenanthrol preserved cellular viability. Furthermore, knockdown of TRPM4 channels preserved the viability of H9c2 cardiomyocytes exposed to H2O2. These results suggest that TRPM4 channels are involved in development of cardiac ischemia-reperfusion injury. Figure 1. Animal experimental protocol Group 1 was pretreated with the vehicle (DMSO), and Group 2 was pretreated with 9-Phe (1 mg/kg i.v.). Both groups were exposed to 30 min of ischemia by occluding left anterior descending artery (LAD), followed by 120 min of reperfusion. Then the hearts were collected for TTC staining. Figure 2. Impact of 9-Phe on the size of myocardial infarction (A), percentage of area at risk (AAR) caused by ischemia-reperfusion injury. (B), percent infarct size to ischemic region (AAR). The percent infarcted area in the 9-Phe group (n = 6) was 3.5-fold smaller than that of the DMSO group (n = 5; *p < 0.01). (C), typical TTC-stained heart slices, corresponding to the groups indicated on the X axis. Blue region indicates cardiac tissue that received normal blood flow. In contrast, red region indicates ischemic tissue due to LAD occlusion. The light red region encircled by a dotted line indicates infarcted tissue. Figure 3. Expression of TRPM4 in the rat heart (A), Specificity of the TRPM4 staining (green) was confirmed by pre- incubation of blocking peptide for TRPM4 antibody. Scale bar: 100 μm. (B), Expression of TRPM4 (green) and SERCA2 (red). Overlaid image (left bottom) indicates that TRPM4 and SERCA2 proteins are alternately located in the longitudinal direction of cardiomyocytes. Arrowheads indicate the intercalated disc. Scale bar: 20 μm. Figure 4. Protective effect of 9-Phe against H2O2- and hypoxia/reoxygenation-induced death of H9c2 cardiomyocytes Cellular viability was quantified by dissolving the formazan crystals, and reading the absorbance of the samples (MTT assay). (A), Cells were exposed to D-MEM medium containing 200 µM H2O2 for 4 h. 9-Phe protected the cells from H2O2 challenge. n = 5 for each condition. (B), Cells were subjected to 4 h anoxia, followed by 1 h reoxygenation. Absorbance was normalized to that of normoxic condition. n = 3 for each condition. *:p < 0.05, **: p < 0.01, N.S.: p > 0.05. Figure 5. Knockdown of TRPM4 prevents cell death caused by H2O2- and hypoxia/reoxygenation-challenge in H9c2 cardiomyocytes (A), Quantitative RT-PCR confirming gene silencing of TRPM4. siNEG: cells transfected with control siRNA, siTRPM4: cells transfected with TRPM4 targeting siRNA. n = 5 for each group. (B), Confirmation of suppressed TRPM4 protein expression by immunocytochemistry 48 h after siRNA transfection. Green: TRPM4, Blue: Hoechst 33342. Fluorescent images were overlaid with DIC images of the tissue. (C), Confirmation of suppressed TRPM4 protein expression by Western blot 24 h after siRNA transfection. (D, E), Impact of gene silencing and pharmacological block of TRPM4 on the 200 µM-H2O2 (D)- and hypoxia/reoxygenation (E)- challenge. Cell viability was measured by the MTT assay. n = 5 for each group. *: p < 0.05, **: p < 0.01, N.S.: p > 0.05. Figure S1. Analysis of TRPM4 expression in organs. TRPM4 protein detected by immunohistochemistry. Organ sections were stained with anti-TRPM4 antibodies. Brown regions indicate positive TRPM4 staining. (A) TRPM4 expression in the rat ventricle, atrium, kidney, and liver. Ab (−): without primary antibody, Ab (+): with primary antibody. Scale for x5 magnification: 200 μm, Scale for x20 magnification: 50 μm. A B A B A B C D E ventricle atrium kidney liver x5 Ab(-) x5 Ab(+) x20 Ab(+) LAD occlusion Adult male SD rats in vivo surgery

×